Inpatient Neurology Consultations During the Onset of the SARS-CoV-2 New York City Pandemic: A Single Center Case Series

Frontiers in Neurology

Amelia Boehme¹  Juan C. Duran²  Jennifer M. Bain²  Steven D. Shapiro³  Tommy J. Wilson³  Sara Radmard³  Kiran T. Thakur³  Joshua Z. Willey³  Samantha E. Epstein³  Hannah J. Roeder³  Andrew J. Michalak³ 

[1] Department of Neurology and Epidemiology, Sergievsky Center, Columbia University Irving Medical Center, New York, NY, United States;Department of Neurology, Division of Child Neurology, New York-Presbyterian/Columbia University Medical Center, New York, NY, United States;Department of Neurology, New York-Presbyterian/Columbia University Irving Medical Center, New York, NY, United States;

关键词: neurology;    novel coronavirus;    COVID-19;    severe acute respiratory syndrome coronavirus 2;    inpatient consults;   

DOI  :  10.3389/fneur.2020.00805

来源: DOAJ

【 摘 要 】

Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily causes respiratory illness. However, neurological sequelae from novel coronavirus disease 2019 (COVID-19) can occur. Patients with neurological conditions may be at higher risk of developing worsening of their underlying problem. Here we document our initial experiences as neurologic consultants at a single center quaternary hospital at the epicenter of the COVID-19 pandemic.Methods: This was a retrospective case series of adult patients diagnosed with SARS-CoV-2 who required neurological evaluation in the form of a consultation or primary neurological care from March 13, 2020 to April 1, 2020.Results: Thirty-three patients (ages 17–88 years) with COVID-19 infection who required neurological or admission to a primary neurology team were included in this study. The encountered neurological problems associated with SARS-CoV-2 infection were encephalopathy (12 patients, 36.4%), seizure (9 patients, 27.2%), stroke (5 patients, 15.2%), recrudescence of prior neurological disease symptoms (4 patients, 12.1%), and neuromuscular (3 patients, 9.1%). The majority of patients who required evaluation by neurology had elevated inflammatory markers. Twenty-one (63.6%) patients were discharged from the hospital and 12 (36.4%) died from COVID-19 related complications.Conclusion: This small case series of our initial encounters with COVID-19 infection describes a range of neurological complications which are similar to presentations seen with other critical illnesses. COVID-19 infection did not change the overall management of neurological problems.

【 授权许可】

Unknown